Scout Investments Inc. lessened its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 4.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 180,106 shares of the medical instruments supplier’s stock after selling 8,092 shares during the period. […]
Congress Wealth Management LLC DE trimmed its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 1.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 77,454 shares of the medical instruments supplier’s stock after selling 1,080 shares […]
LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) and InspireMD (NYSE:NSPR – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations. Volatility and Risk LeMaitre Vascular has a beta […]
LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) Director Bridget A. Ross sold 5,500 shares of the firm’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $77.99, for a total value of $428,945.00. Following the completion of the sale, the director now owns 2,278 shares in […]
LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) and InspireMD (NYSE:NSPR – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk. Insider & Institutional Ownership 84.6% of LeMaitre Vascular […]